Tapering of TNF inhibitors in axial spondyloarthritis in routine care-2-year clinical and MRI outcomes and predictors of successful tapering.
Marie WetterslevStylianos GeorgiadisInge Juul SørensenSusanne Juhl PedersenSara Nysom ChristiansenMerete Lund HetlandCecilie Heegaard BraheMads BakkegaardAnne DuerMikael BoesenKasper Kjærulf GosvigJakob Møllenbach MøllerNiels Steen KroghBente JensenOle Rintek MadsenJan ChristensenAnnette HansenJesper NørregaardHenrik RøgindMikkel ØstergaardPublished in: Rheumatology (Oxford, England) (2021)
After two years following a clinical guideline, 52% of patients with axSpA in clinical remission had successfully tapered TNFi, only 1% discontinued. Baseline physician global score was an independent predictor of successful tapering.